![Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels | Science Translational Medicine Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.3001513/asset/62b09e6e-9cd8-414d-a38c-2751ff288b2c/assets/graphic/2-62ra92-f1.jpeg)
Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels | Science Translational Medicine
![Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2004/nejm_2004.350.issue-22/nejmoa031918/production/images/img_medium/nejmoa031918_t1.jpeg)
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM
![Place du PSA et des marqueurs prostatiques dans le dépistage et le diagnostic du cancer de la prostate | Cairn.info Place du PSA et des marqueurs prostatiques dans le dépistage et le diagnostic du cancer de la prostate | Cairn.info](https://www.cairn.info/cover/width-204/HEG/HEG_011.jpg?fallback=true)
Place du PSA et des marqueurs prostatiques dans le dépistage et le diagnostic du cancer de la prostate | Cairn.info
The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trial | PLOS ONE
![Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2004/nejm_2004.350.issue-22/nejmoa031918/production/images/img_medium/nejmoa031918_f1.jpeg)
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM
![Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target | Journal of Medicinal Chemistry Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.0c02039/asset/images/large/jm0c02039_0007.jpeg)
Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target | Journal of Medicinal Chemistry
![Reproductive and endocrinological effects of Benign Prostatic Hyperplasia and finasteride therapy in dogs | Scientific Reports Reproductive and endocrinological effects of Benign Prostatic Hyperplasia and finasteride therapy in dogs | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-71691-7/MediaObjects/41598_2020_71691_Fig1_HTML.png)
Reproductive and endocrinological effects of Benign Prostatic Hyperplasia and finasteride therapy in dogs | Scientific Reports
![Cancers | Free Full-Text | Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data Cancers | Free Full-Text | Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data](https://www.mdpi.com/cancers/cancers-15-00261/article_deploy/html/images/cancers-15-00261-g001.png)
Cancers | Free Full-Text | Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data
![Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2004/nejm_2004.350.issue-22/nejmoa031918/production/images/img_medium/nejmoa031918_t2.jpeg)
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM
![Leveraging Genetic Determinants of Prostate-Specific Antigen Levels Towards Improving Prostate Cancer Screening | medRxiv Leveraging Genetic Determinants of Prostate-Specific Antigen Levels Towards Improving Prostate Cancer Screening | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2022/10/07/2022.04.18.22273850/F5.large.jpg)